Although this scenario is common for all types of cancer, a deeper study of the E2F1 and E2F4 genes, and depending on those prioritized in Communities 4 and 9 along with TP53, would be necessary to define driver proteins in OS tumors. This evidence concerns the gene E2F4 and cancer.